Symbio Proinnovera
Pharmaceuticals, 21 Perry Street, Port Jefferson, New York, 11777, United States, 51-200 Employees
Who is SYMBIO PROINNOVERA
The newly announced merger of NY-headquartered Symbio LLC and CA-headquartered Dow Development Laboratories LLC with Munster (Germany)-based Proinnovera will form Symbio Proinnovera, crea...
Read More
-
Headquarters: 21 Perry Street, Port Jefferson, New York, 11777, United States
-
Date Founded: 2002
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8731
|
NAICS Code: 541715 |
Show More
Does something look wrong? Fix it. | View contact records from SYMBIO PROINNOVERA
Symbio Proinnovera Org Chart and Mapping
Email
Phone
Similar Companies to Symbio Proinnovera
Catawba Research
-
51-200
-
$ 10 Million to 25 Million
Clinical ink
-
201-500
-
$ 100 Million to 250 Million
ERGOMED
-
1001-5000
-
$ 50 Million to 100 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Symbio Proinnovera
Answer: Symbio Proinnovera's headquarters are located at 21 Perry Street, Port Jefferson, New York, 11777, United States
Answer: Symbio Proinnovera's official website is https://symbioresearch.com
Answer: Symbio Proinnovera's revenue is $25 Million to $50 Million
Answer: Symbio Proinnovera's SIC: 8731
Answer: Symbio Proinnovera's NAICS: 541715
Answer: Symbio Proinnovera has 51-200 employees
Answer: Symbio Proinnovera is in Pharmaceuticals
Answer: Symbio Proinnovera top competitors include: Catawba Research , Clinical ink , ERGOMED
Answer: Symbio Proinnovera contact info: Phone number: Website: https://symbioresearch.com
Answer: The newly announced merger of NY-headquartered Symbio LLC and CA-headquartered Dow Development Laboratories LLC with Munster (Germany)-based Proinnovera will form Symbio Proinnovera, creating one of the worlds largest specialized dermatology-focused clinical research organizations. Founded over 20 years ago, the Symbio & Dow Group has a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client's dermatology and aesthetics services - from pre-clinical formulation work to subsequent clinical trial execution. Proinnovera was founded 25 years ago and is a leading European CRO in the dermatology clinical trial space. It is a full-service CRO conducting clinical studies from Phase I to IV, as well as non-interventional and medical device studies. Proinnovera turns study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials. Both companies are proven market leaders among specialty dermatology CROs with exceptional geographical coverage. Their combined strength will enable them to excel at addressing customers needs and expectations in all areas of research. The newly formed organization will leverage the combined power of two highly experienced teams with deep expertise in the dermatology space to generate efficiencies and accelerate clinical research. Symbio Proinnovera will be supported in its growth by ARCHIMED, a leading investment firm focused exclusively on healthcare industries.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month